SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant Life Sciences receives credit rating of ‘A1+’ from CRISIL

03 May 2017 Evaluate

Jubilant Life Sciences has received credit rating of ‘A1+’ from CRISIL for commercial paper programme of Rs 400 crore. The ratings are in addition to credit rating of 'A+' issued by India Ratings and Research on September 30, 2016 for Rs 450 crore commercial paper/ Short Term Debt Programme of the company.

Jubilant Life Sciences is an integrated global Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Life Science Ingredients.

Jubilant Pharmova Share Price

906.35 -5.25 (-0.58%)
20-Apr-2026 11:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1674.00
Dr. Reddys Lab 1236.85
Cipla 1237.20
Zydus Lifesciences 941.70
Lupin 2324.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×